CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hyliion Holdings Corp. ("Hyliion" or the "Company") (NYSE American: HYLN) on behalf of investors that purchased or otherwise acquired Hyliion securities between May 12, 2026 and June 23, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hyliion and have suffered losses, you may CLICK HERE to contact us.
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against GPGI, Inc. f/k/a CompoSecure, Inc. (NYSE: GPGI) (NYSE: CMPO) on behalf of investors that purchased or otherwise acquired GPGI Class A common stock between November 3, 2025 and May 6, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in GPGI and have suffered losses, you may CLICK HERE to contact us.
Debuting during the 2026 football season on a streaming service, the new campaign marks 120 years of Coldwell Banker affiliated agents handing families the keys to the places where their lives unfold. MADISON, N.J.
The software sector is on pace to outperform the chip sector by a historic degree in the face of escalating AI fears.
LOS ANGELES, Sept. 14, 2026 /PRNewswire/ -- The Law Offices of Frank R.
The last couple of days have certainly been interesting for AI bulls and bears alike. Key Takeaways: It's been a tale of two cities for AI investors as of late, with breakout Oracle earnings coming out amid growing calls to slow down the pace of AI development.
It's no secret that valuations are quite high, but what do investors and advisors make of that? On the one hand, there's plenty of equities still out there in these early stages of the AI revolution.
I rate Meta Platforms a Buy, with a price target of $817 per share, representing 26% upside from the current level. META's Q2 2026 showed robust ad revenue growth, with impressions up 14% and average price per ad up 12%, supporting strong earnings momentum. The valuation also looks more attractive when viewed through a growth lens because META's 1.03x FWD non-GAAP PEG is 18.35% below the sector median and more than 31% below the 5-year average.
Blue Owl Capital Inc. (OWL) Presents at Barclays 24th Annual Global Financial Services Conference Transcript
Drugmaker Hims & Hers Health Inc (NYSE:HIMS) stock is moving 6.6% higher to trade at $29.34 this afternoon.